{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:46:23Z","timestamp":1768884383243,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroimaging Clinics of North America"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.nic.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T05:47:51Z","timestamp":1605764871000},"page":"121-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Adult Primary Brain Neoplasm, Including 2016 World Health Organization Classification"],"prefix":"10.1016","volume":"31","author":[{"given":"Kevin Yuqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie M.","family":"Malayil Lincoln","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nic.2020.09.011_bib1","series-title":"Osborn\u2019s brain","author":"Osborn","year":"2018"},{"issue":"suppl_4","key":"10.1016\/j.nic.2020.09.011_bib2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.nic.2020.09.011_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2176\/nmc.ra.2017-0010","article-title":"The 2016 WHO classification of tumours of the central nervous system: the major points of revision","volume":"57","author":"Komori","year":"2017","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"6","key":"10.1016\/j.nic.2020.09.011_bib4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.nic.2020.09.011_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00701-016-3062-3","article-title":"The new WHO 2016 classification of brain tumors-what neurosurgeons need to know","volume":"159","author":"Banan","year":"2017","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"10.1016\/j.nic.2020.09.011_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00401-018-1808-0","article-title":"cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC)","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.nic.2020.09.011_bib7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/bpa.12563","article-title":"Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features","volume":"28","author":"Bielle","year":"2018","journal-title":"Brain Pathol"},{"issue":"7","key":"10.1016\/j.nic.2020.09.011_bib8","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1148\/rg.2017170037","article-title":"2016 updates to the WHO brain tumor classification system: what the radiologist needs to know","volume":"37","author":"Johnson","year":"2017","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.nic.2020.09.011_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","article-title":"Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951","volume":"31","author":"van den Bent","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.nic.2020.09.011_bib10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1200\/JCO.2013.49.3726","article-title":"Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH","volume":"32","author":"Cairncross","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.nic.2020.09.011_bib11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMoa1500925","article-title":"Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma","volume":"374","author":"Buckner","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.nic.2020.09.011_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-015-1409-0","article-title":"Molecular classification of diffuse cerebral WHO grade II\/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups","volume":"129","author":"Weller","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.nic.2020.09.011_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng.3273","article-title":"Mutational landscape and clonal architecture in grade II and III gliomas","volume":"47","author":"Suzuki","year":"2015","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.nic.2020.09.011_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00401-015-1398-z","article-title":"IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas","volume":"129","author":"Olar","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.nic.2020.09.011_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10014-016-0249-5","article-title":"Calcification on CT is a simple and valuable preoperative indicator of 1p\/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas","volume":"33","author":"Saito","year":"2016","journal-title":"Brain Tumor Pathol"},{"issue":"2","key":"10.1016\/j.nic.2020.09.011_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5414\/NP301085","article-title":"H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis","volume":"37 (2018)","author":"Kleinschmidt-DeMasters","year":"2018","journal-title":"Clin Neuropathol"},{"issue":"4","key":"10.1016\/j.nic.2020.09.011_bib17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00432-018-02836-5","article-title":"High frequency of H3 K27M mutations in adult midline gliomas","volume":"145","author":"Ebrahimi","year":"2019","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.nic.2020.09.011_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-018-1826-y","article-title":"cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma\/anaplastic astrocytoma, IDH-mutant","volume":"135","author":"Louis","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nic.2020.09.011_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/modpathol.3800999","article-title":"The prognostic value of histological grading of posterior fossa ependymomas in children: a Children\u2019s Oncology Group study and a review of prognostic factors","volume":"21","author":"Tihan","year":"2008","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.nic.2020.09.011_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"issue":"7489","key":"10.1016\/j.nic.2020.09.011_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature13108","article-title":"Epigenomic alterations define lethal CIMP-positive ependymomas of infancy","volume":"506","author":"Mack","year":"2014","journal-title":"Nature"},{"issue":"7489","key":"10.1016\/j.nic.2020.09.011_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","article-title":"C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma","volume":"506","author":"Parker","year":"2014","journal-title":"Nature"},{"issue":"65","key":"10.1016\/j.nic.2020.09.011_bib23","doi-asserted-by":"crossref","first-page":"109175","DOI":"10.18632\/oncotarget.22646","article-title":"Histopathological, molecular, clinical and radiological characterization of rosette-forming glioneuronal tumor in the central nervous system","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.nic.2020.09.011_bib24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp-2014-309805","article-title":"Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosis","volume":"87","author":"Yu","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.nic.2020.09.011_bib25","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s10072-018-3459-2","article-title":"Letter to the editor: lung metastasis in WHO grade I meningioma","volume":"39","author":"Simonetti","year":"2018","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.nic.2020.09.011_bib26","first-page":"101","article-title":"New CT finding in aggressive meningioma","volume":"6","author":"Shapir","year":"1985","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.nic.2020.09.011_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00000478-199003000-00002","article-title":"Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome","volume":"14","author":"Carney","year":"1990","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 3","key":"10.1016\/j.nic.2020.09.011_bib28","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1007\/s00247-015-3282-3","article-title":"Neuroimaging of phakomatoses: overview and advances","volume":"45","author":"Vezina","year":"2015","journal-title":"Pediatr Radiol"},{"issue":"2","key":"10.1016\/j.nic.2020.09.011_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.nic.2020.09.011_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.2522","article-title":"Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors","volume":"45","author":"Chmielecki","year":"2013","journal-title":"Nat Genet"}],"container-title":["Neuroimaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514920300885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514920300885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:05:10Z","timestamp":1760943910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052514920300885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1052514920300885"],"URL":"https:\/\/doi.org\/10.1016\/j.nic.2020.09.011","relation":{},"ISSN":["1052-5149"],"issn-type":[{"value":"1052-5149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult Primary Brain Neoplasm, Including 2016 World Health Organization Classification","name":"articletitle","label":"Article Title"},{"value":"Neuroimaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nic.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}